SCHEMBL20723733

SCHEMBL20723733

C=CCc1ccc(OC(=O)c2ccc([N+](=O)[O-])cc2)c(OC)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
PRSS1 P07477 1/20 0.64
ACR P10323 1/20 0.64
PTGS1 P23219 1/20 0.62
ALDH1A1 P00352 3/20 0.55
PPARA Q07869 2/20 0.55
PPARG P37231 1/20 0.55
PPARD Q03181 1/20 0.55
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 3/20 0.51
HTT P42858 2/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31438945 0.84 MEN1 (0.79) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL22283382 0.84 MEN1 (0.79) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL28027154 0.84 KMT2A (0.78) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL20723696 0.84 PTGS1 (0.56) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL20723735 0.83 MEN1 (0.77) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL28416133 0.83 KMT2A (0.77) CYP3A4MEN1KMT2AL3MBTL1TDP1
Eugenyl Benzoat SCHEMBL31089296 0.83 MEN1 (1.00) CYP3A4MEN1KMT2AL3MBTL1TDP1
Eugenyl Benzoat SCHEMBL357066 0.83 MEN1 (1.00) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL22171679 0.80 MEN1 (0.85) CYP3A4MEN1KMT2AL3MBTL1TDP1
SCHEMBL2790411 0.80 KMT2A (0.71) CYP3A4MEN1KMT2AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019030643-A1 COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2019-02-14 WO claimed